Clinical Trial

TheraSphere Japan Pre-Market Study

Name: TheraSphere Japan Pre-Market Study — clinical trial record (NCT07377487)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INDIGO

Recruiting

View on ClinicalTrials.gov →

Summary

To investigate the safety and effectiveness of BSJ019T in Japanese patients with primary or secondary liver who are not candidate for standard treatment.

Protocol Amendment History 2 changes

notable Primary completion pushed: 2027-03-31 -> 2027-06-30 2026-03-31

minor Completion pushed: 2027-04-30 -> 2027-12-31 2026-03-31

Trial Details

NCT Number	NCT07377487
Lead Sponsor	Boston Scientific Corporation
Conditions	Liver Neoplasms
Enrollment	51 participants
Start Date	2026-01-22
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-23